Sector footprint
$700.8K in exports
Reported chemicals exports in 2024 across 29 qualifying HS6 products.
Sector export playbook ยท HS 28-38
Vanuatu Chemicals exports
where capability meets demand
Explore Vanuatu's HS 28-38 product portfolio, buyer markets, growth signals, and diversification opportunities. Use this guide to prioritize research, not to treat calculated indicators as guaranteed sales.
Sector exports$700.8K2024 reported value
Products29Qualifying HS6 products
Buyer markets28Markets represented
Average CAGR-3.7%Product-level growth signal
Global sector size$202.9BReported buyer imports
Chemicals capability
How strong is Vanuatu in this sector?
Compare exporter scale with product breadth, buyer demand, growth, and destination reach. A large sector does not remove the need for product, compliance, pricing, and buyer validation.
Global demand
$202.9B buyer imports
The sector's reported buyer import base provides context for product and market prioritization.
How to use the guide
Find the next credible move
Start with products that combine demand and exporter capability, then validate standards, route economics, buyers, and competition.
Product portfolio
Which products anchor the sector?
Each HS6 product is ranked by calculated opportunity and shown with reported market size, exporter exports, growth, and destination reach.
| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
|---|---|---|---|---|---|---|
| HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $167.0B | $144.7K | $66.4B | -10.4% | 17 | +0.0% |
| HS 330499Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $21.5B | $84.6K | $7.8B | -4.4% | 15 | +0.0% |
| HS 300439Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $3.0B | $9.1K | $2.0B | +9.6% | 1 | +0.0% |
| HS 382200Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $2.7B | $20.9K | $1.4B | +2.7% | 4 | +0.0% |
| HS 300390Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $2.0B | $34.4K | $1.3B | +35.1% | 2 | +0.0% |
| HS 330590Hair preparations: n.e.s. in heading no. 3305 | $2.1B | $16.8K | $674.1M | -15.4% | 4 | +0.0% |
| HS 330300Perfumes and toilet waters | $852.7M | $114.8K | $365.0M | +29.1% | 3 | +0.0% |
| HS 330129Oils, essential: n.e.s. in heading no. 3301 (terpeneless or not), including concretes and absolutes | $1.2B | $192.5K | $332.7M | -4.0% | 7 | +0.0% |
| HS 300290Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $274.0M | $912.7 | $189.6M | +59.5% | 1 | +0.0% |
| HS 382499Chemical products, mixtures and preparations: n.e.c. heading 3824 | $252.4M | $4.9 | $132.7M | -88.6% | 1 | +0.0% |
| HS 340220Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $170.4M | $2.9 | $120.6M | -73.3% | 1 | +0.0% |
| HS 293134Organo-inorganic compounds: organo-phosphorus derivatives, sodium-3-(hydroxysilyl)propyl methylphosphonate | $71.8M | $447.5 | $116.3M | -6.0% | 1 | +8.2% |
| HS 330190Oils, essential: concentrates in fats, fixed oils, waxes and the like, terpenic by-products, aqueous distillates and solutions, extracted oleoresins, n.e.c. in heading no. 3301 | $146.1M | $17.8K | $114.2M | +46.5% | 2 | +0.0% |
| HS 293690Vitamins: n.e.c. in heading no. 2936, including natural concentrates | $138.1M | $3.2K | $102.2M | -3.3% | 2 | +0.0% |
| HS 330410Cosmetic and toilet preparations: lip make-up | $255.1M | $17.7K | $99.3M | -9.7% | 1 | +0.0% |
| HS 330420Cosmetic and toilet preparations: eye make-up | $278.2M | $7.8K | $93.7M | -40.9% | 2 | +0.0% |
| HS 300450Medicaments: containing vitamins or their derivatives, for therapeutic or prophylactic use, packaged for retail sale | $157.0M | $30.9K | $49.0M | -17.8% | 1 | +0.0% |
| HS 330510Hair preparations: shampoos | $53.5M | $23.7 | $47.2M | -52.7% | 1 | +0.0% |
| HS 340111Soap and organic surface-active products: in the form of bars, cakes, moulded shapes, and paper, wadding, felt and nonwovens, impregnated, coated or covered with soap or detergent, for toilet use (including medicated products) | $95.5M | $1.3K | $45.8M | +21.3% | 2 | +0.0% |
| HS 293190Organo-inorganic compounds: other than tetramethyl lead, tetraethyl lead, and tributyltin compounds | $51.3M | $447.5 | $43.1M | -6.0% | 1 | +0.0% |
| HS 330290Odoriferous substances and mixtures: used as raw materials in industries other than the food or drink industries | $187.0M | $92.6 | $40.1M | -3.6% | 1 | +0.0% |
| HS 300339Medicaments: containing hormones (excluding insulin), (but not containing antibiotics), for therapeutic or prophylactic uses, not packaged for retail sale | $18.1M | $73.8 | $29.5M | +123.5% | 1 | +0.0% |
| HS 300190Glands and other organs: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, n.e.c. in heading 3001 | $31.1M | $1.6K | $27.6M | +86.8% | 1 | +0.0% |
| HS 330610Oral or dental hygiene preparations: dentifrices | $25.7M | $17.9 | $24.5M | -73.0% | 1 | +0.0% |
| HS 340120Soap: in forms n.e.c. in item no. 3401.11 | $109.8M | $2.7 | $24.2M | -34.9% | 1 | +0.0% |
| HS 340290Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), including auxiliary washing preparations, not for retail sale | $73.4M | $2.3 | $24.1M | -29.0% | 1 | +0.0% |
| HS 321519Ink: for printing, other than black, whether or not concentrated or solid | $116.1M | $62.5 | $19.5M | -27.4% | 1 | +0.0% |
| HS 300650Pharmaceutical goods: first aid boxes and kits | $14.8M | $56.2 | $17.6M | -13.7% | 1 | +0.0% |
| HS 292910Nitrogen-function compounds: n.e.c. in chapter 29, isocyanates | $21.5M | $525.5 | $16.3M | -20.1% | 1 | +0.0% |
Best markets
Where does sector demand concentrate?
Markets are ranked by calculated opportunity across the qualifying products in this sector view.
CHE
Switzerland, Liechtenstein
1 products represented in the sector.
$27.7B$41.0B reported buyer importsUSA
USA, Puerto Rico and US Virgin Islands
8 products represented in the sector.
$22.6B$85.9B reported buyer importsGBR
United Kingdom
9 products represented in the sector.
$7.6B$21.3B reported buyer importsNLD
Netherlands
2 products represented in the sector.
$5.6B$11.8B reported buyer importsCAN
Canada
3 products represented in the sector.
$5.0B$9.4B reported buyer importsIRL
Ireland
11 products represented in the sector.
$4.2B$7.7B reported buyer importsAUS
Australia
12 products represented in the sector.
$1.6B$6.3B reported buyer importsHKG
China, Hong Kong Special Administrative Region
2 products represented in the sector.
$936.3M$2.6B reported buyer importsSGP
Singapore
2 products represented in the sector.
$829.4M$2.0B reported buyer importsJPN
Japan
1 products represented in the sector.
$710.3M$1.3B reported buyer importsDEU
Germany
2 products represented in the sector.
$702.6M$2.5B reported buyer importsLUX
Luxembourg
1 products represented in the sector.
$573.6M$577.8M reported buyer importsGrowth stars
Which products show the strongest growth?
Average product-level CAGR is a screening signal. Confirm the latest trend, base effects, buyer quality, and commercial feasibility before acting.
| Product | Average CAGR | Opportunity | Markets |
|---|---|---|---|
| HS 300339Medicaments: containing hormones (excluding insulin), (but not containing antibiotics), for therapeutic or prophylactic uses, not packaged for retail sale | +123.5% | $29.5M | 1 |
| HS 300190Glands and other organs: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, n.e.c. in heading 3001 | +86.8% | $27.6M | 1 |
| HS 300290Toxins, cultures of micro-organisms (excluding yeasts) and similar products | +59.5% | $189.6M | 1 |
| HS 330190Oils, essential: concentrates in fats, fixed oils, waxes and the like, terpenic by-products, aqueous distillates and solutions, extracted oleoresins, n.e.c. in heading no. 3301 | +46.5% | $114.2M | 2 |
| HS 300390Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | +35.1% | $1.3B | 2 |
| HS 330300Perfumes and toilet waters | +29.1% | $365.0M | 3 |
| HS 340111Soap and organic surface-active products: in the form of bars, cakes, moulded shapes, and paper, wadding, felt and nonwovens, impregnated, coated or covered with soap or detergent, for toilet use (including medicated products) | +21.3% | $45.8M | 2 |
| HS 300439Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | +9.6% | $2.0B | 1 |
| HS 382200Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | +2.7% | $1.4B | 4 |
| HS 293690Vitamins: n.e.c. in heading no. 2936, including natural concentrates | -3.3% | $102.2M | 2 |
Diversification opportunities
Which products reach the widest buyer base?
Destination count is a simple breadth indicator. It does not measure destination concentration or guarantee resilience.
HS 300490
Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale
17 markets$66.4B calculated opportunityHS 330499
Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations)
15 markets$7.8B calculated opportunityHS 330129
Oils, essential: n.e.s. in heading no. 3301 (terpeneless or not), including concretes and absolutes
7 markets$332.7M calculated opportunityHS 382200
Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material
4 markets$1.4B calculated opportunityHS 330590
Hair preparations: n.e.s. in heading no. 3305
4 markets$674.1M calculated opportunityHS 330300
Perfumes and toilet waters
3 markets$365.0M calculated opportunityHS 300390
Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale)
2 markets$1.3B calculated opportunityHS 330190
Oils, essential: concentrates in fats, fixed oils, waxes and the like, terpenic by-products, aqueous distillates and solutions, extracted oleoresins, n.e.c. in heading no. 3301
2 markets$114.2M calculated opportunityFrequently asked questions
Using the Chemicals export playbook
Practical guidance for interpreting sector scale, growth, product breadth, and buyer markets.
How strong is Vanuatu in this sector?
Compare sector exports, product breadth, buyer markets, growth, and global demand. These signals identify research priorities rather than guarantee market access.
What are growth stars?
Products with higher average reported growth in the screened rows. Validate the time period, base effects, buyer demand, and current exporter position.
What does diversification mean here?
Products reaching more buyer markets in the screened data. Destination breadth is useful context but does not replace concentration, route, or buyer analysis.
Data source
OECD trade statistics with CEPII context
OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). OECD BIMTS is the primary trade series for this view. Supporting bilateral trade context uses CEPII BACI bilateral trade flows (202601) under Etalab 2.0 Open Licence. Yugalinks presents derived views of reported observations and calculated indicators. Data terms: OECD Terms & Conditions.